Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janneke C van den Bergen

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Muscle & Nerve|April 8, 2015
T2 relaxation times are increased in Skeletal muscle of DMD but not BMD patientsBeatrijs H Wokke, Janneke C Van Den Bergen, Melissa T Hooijmans, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 30, 2009
[Experimental therapy in Duchenne muscular dystrophy]Janneke C van den Bergen, Chiara S M Straathof, Annemieke Aartsma-Rus, et al.
Journal of Pediatric Hematology/Oncology|December 22, 2021
In Response to: Pediatric Myelodysplastic Syndrome with Germline RRAS Mutation: Expanding the Phenotype of RASopathiesNienke van Engelen, Illja Diets, Dorine Bresters, et al.
Plos One|December 16, 2014
Age-related longitudinal changes in metabolic energy expenditure during walking in boys with Duchenne muscular dystrophyMerel-Anne Brehm, Jiska C E Kempen, Anneke J van der Kooi, et al.
Muscle & Nerve|April 23, 2015
Diagnosis of becker muscular dystrophy: Results of Re-analysis of DNA samplesChiara S M Straathof, Dave Van Heusden, Pieternella F Ippel, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 27, 2013
DMD transcript imbalance determines dystrophin levelsPietro Spitali, Janneke C van den Bergen, Ingrid E C Verhaart, et al.
Annals of Neurology|July 22, 2014
Reduced cerebral gray matter and altered white matter in boys with Duchenne muscular dystrophyNathalie Doorenweerd, Chiara S Straathof, Eve M Dumas, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 6, 2014
Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variantsJanneke C van den Bergen, Monika Hiller, Stefan Böhringer, et al.
Human Mutation|January 22, 2015
The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutationsCatherine L Bladen, David Salgado, Soledad Monges, et al.
Journal of Neuromuscular Diseases|November 11, 2017
Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global DatabaseZaïda Koeks, Catherine L Bladen, David Salgado, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Muscle & Nerve|April 8, 2015
T2 relaxation times are increased in Skeletal muscle of DMD but not BMD patientsBeatrijs H Wokke, Janneke C Van Den Bergen, Melissa T Hooijmans, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 30, 2009
[Experimental therapy in Duchenne muscular dystrophy]Janneke C van den Bergen, Chiara S M Straathof, Annemieke Aartsma-Rus, et al.
Journal of Pediatric Hematology/Oncology|December 22, 2021
In Response to: Pediatric Myelodysplastic Syndrome with Germline RRAS Mutation: Expanding the Phenotype of RASopathiesNienke van Engelen, Illja Diets, Dorine Bresters, et al.
Plos One|December 16, 2014
Age-related longitudinal changes in metabolic energy expenditure during walking in boys with Duchenne muscular dystrophyMerel-Anne Brehm, Jiska C E Kempen, Anneke J van der Kooi, et al.
Muscle & Nerve|April 23, 2015
Diagnosis of becker muscular dystrophy: Results of Re-analysis of DNA samplesChiara S M Straathof, Dave Van Heusden, Pieternella F Ippel, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 27, 2013
DMD transcript imbalance determines dystrophin levelsPietro Spitali, Janneke C van den Bergen, Ingrid E C Verhaart, et al.
Annals of Neurology|July 22, 2014
Reduced cerebral gray matter and altered white matter in boys with Duchenne muscular dystrophyNathalie Doorenweerd, Chiara S Straathof, Eve M Dumas, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 6, 2014
Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variantsJanneke C van den Bergen, Monika Hiller, Stefan Böhringer, et al.
Human Mutation|January 22, 2015
The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutationsCatherine L Bladen, David Salgado, Soledad Monges, et al.
Journal of Neuromuscular Diseases|November 11, 2017
Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global DatabaseZaïda Koeks, Catherine L Bladen, David Salgado, et al.
Pageof 2